(5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one

Basic Information

View in Editor

CAS Number

65-04-3

Molecular Formula

C20H30O2

Molecular Weight

302.5 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ketones

Fine Chemicals Surfactants Anionic Surfactants

Basic Physical Properties

Melting Point

154-155 ºC

Boiling Point

422.719 °C at 760 mmHg

Density

1.082

Flash Point

180.4 °C

Solubility

H2O: ≤0.5 mg/mL

SMILES

View in Editor

CC12CCC3C(C1CCC2(C)O)CCC4C3(C=CC(=O)C4)C

InChI

InChI=1S/C20H30O2/c1-18-9-6-14(21)12-13(18)4-5-15-16(18)7-10-19(2)17(15)8-11-20(19,3)22/h6,9,13,15-17,22H,4-5,7-8,10-12H2,1-3H3/t13-,15+,16-,17-,18-,19-,20-/m0/s1

InChIKey

JRNSSSJKIGAFCT-YDSAWKJFSA-N

LogP

4.125200000000004

Topological Polar Surface Area

37.3 Å²

Hydrogen Bond Donor/Acceptor

1 / 2

Complexity

538

Synonyms & References

English

21O907N0NH
17.ALPHA.-METHYL-17.BETA.-HYDROXY-.DELTA.1-5.ALPHA.-ANDROSTEN-3-ONE
UNII-21O907N0NH
17.BETA.-HYDROXY-17.ALPHA.-METHYL-5.ALPHA.-ANDROST-1-ENE-3-ONE
AKOS015962937
JRNSSSJKIGAFCT-YDSAWKJFSA-N
Methyl-1-testosterone
SC-11195
17.ALPHA.-METHYL-17.BETA.-HYDROXY-5.ALPHA.-ANDROST-1-EN-3-ONE
17-ALPHA-METHYL-1-TESTOSTERONE
(5S,8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13,17-trimethyl-5,6,7,8,9,11,12,14,15,16-decahydro-4H-cyclopenta[a]phenanthren-3-one
17alpha-Methyl-17-hydroxy-5alpha-androsta-1-ene-3-one
ANDROST-1-EN-3-ONE, 17-HYDROXY-17-METHYL-, (5.ALPHA.,17.BETA.)-
17alpha-Methyl-1-testosterone
18167-94-7
17beta-Hydroxy-17alpha-methyl-5alpha-androst-1-ene-3-one
(+)-Methyl-1-testosterone
SCHEMBL4115261
17alpha-Methyl-17beta-hydroxy-delta1-5alpha-androsten-3-one
OXANDROLONE IMPURITY, .DELTA.1-MESTALONE- [USP IMPURITY]
65-04-3
Q6823920
Oxandrolone impurity, delta1-mestalone- [USP]
17alpha-Methyl-17beta-hydroxy-5alpha-androst-1-en-3-one
Androst-1-en-3-one, 17-hydroxy-17-methyl-, (5alpha,17beta)-
DB01572
(5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one
17-Methyl-1-Testosterone : (5 a ,17 b )-17-Hydroxy-17-methylandrosta-1-en-3-one
17.beta.-hydroxy-17.alpha.-methyl-5.alpha.-androst-1-en-3-one
DTXSID20879831
17beta-hydroxy-17alpha-methyl-5alpha-androst-1-en-3-one

FAQ

What regulatory guidelines apply to (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3)?

The compound (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) is subject to various regulatory guidelines including GHS classification for hazardous materials, REACH regulations for European manufacturers and importers, and FDA/EPA requirements for pharmaceutical and environmental safety. It is also important to comply with local and regional regulations.

Are there alternatives to (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) in synthesis?

In synthesis, alternatives to (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) include its analogs and isomers, such as testosterone or dihydrotestosterone. Common alternative reagents include methylene chloride, acetic anhydride, and other synthetic equivalents, depending on the specific application.

What is the market or research trend for (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3)?

The market for (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) is driven by its use in research and development of hormones and related pharmaceuticals. Recent trends show increasing interest in its application in anti-aging treatments and sports supplements. Research is also focusing on its potential in endocrine studies and drug discovery.

How should waste containing (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) be handled?

Waste containing (5alpha,17beta)-17-Hydroxy-17-methylandrost-1-en-3-one (CAS: 65-04-3) should be collected in a closed container and disposed of by incineration or through professional waste disposal services. Environmental protection measures include proper labeling and containing to prevent leakage, and following local waste management regulations.